Optical Imaging Market by Technique and Product – Global Forecast to 2020

-
According to research report the optical imaging market is expected to be at USD 989.0 Million in 2015, growing at a CAGR of 12.1% during the forecast period. The optical imaging market offers powerful modalities for molecular imaging in clinical diagnostics and preclinical research in various therapeutic areas. Rising aging population, increase in R&D activities in the life sciences sector, and growing demand of optical imaging techniques in drug discovery processes and preclinical research are expected to propel the growth of this market.
Some prominent players in the global optical imaging market are Topcon Medical systems, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Carl Zeiss Meditec AG (Germany), and Bioptigen, Inc. (U.S.), Heidelberg Engineering, Inc. (U.S.), Headwall Photonics, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Optovue, Inc. (U.S.), DermaLumics (Spain), Michelson Diagnostics (U.K.), AGFA Healthcare (Belgium), and Santec Corporation (Japan).
Target Audience:
  • Optical Imaging Device Manufacturers and Distributors
  • Healthcare Institutions (Hospitals, Laboratories, Medical Schools, and Outpatient Clinics)
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Government Associations
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors
Scope of the Report
The research report categorizes the global optical imaging market into the following segments and subsegments:
Global Optical Imaging Market, by Techniques
  • Optical Coherence Tomography
  • Hyperspectral Imaging
  • Near-infrared Spectroscopy
  • Photoacoustic Tomography
Global Optical Imaging Market, by Products

  • Imaging Systems
    • Optical Imaging Systems
    • Spectral Imaging Systems
  • Cameras
  • Software
  • Illumination Systems
  • Lenses
  • Other Optical Imaging Products

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more